anti-Chemokine (C-C Motif) Ligand 28 (CCL28) Anticorps

CCL28 belongs to the subfamily of small cytokine CC genes. De plus, nous expédions CCL28 Protéines (49) et CCL28 Kits (17) et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
CCL28 114492  
CCL28 56477 Q9NRJ3
CCL28 56838 Q9JIL2
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top anti-CCL28 Anticorps sur anticorps-enligne.fr

Showing 10 out of 72 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Livraison Prix Détails
Humain Lapin Inconjugué WB Western blot analysis of CCL28 expression in Jurkat (A), HT29 (B) whole cell lysates. 200 μL 13 to 14 Days
$487.50
Détails
Humain Lapin Inconjugué ELISA, IHC, WB Western blot analysis of Mouse spleen lysate, using CCL28 Antibody. The lane on the left is treated with the antigen-specific peptide. ABIN6277304 at 1/100 staining Mouse colon tissue by IHC-P. The sample was formaldehyde fixed and a heat mediated antigen retrieval step in citrate buffer was performed. The sample was then blocked and incubated with the antibody for 1.5 hours at 22¡ãC. An HRP conjugated goat anti-rabbit antibody was used as the secondary 100 μL 11 to 12 Days
$390.77
Détails
Humain Lapin Inconjugué EIA, IF, WB Sandwich ELISA using MEC / CCL28 antibody Immunofluorescence: This antibody stained CACO-2 cells.  The primary antibody was incubated at 3.0 mg/ml overnight at 4°C followed by a fluorescent labeled secondary antibody. Information and photo are courtesy of the Cell Profiling group, SciLifeLab Stockholm. 50 μg 6 to 8 Days
$313.50
Détails
Humain Lapin Inconjugué IHC, WB 100 μL 11 to 13 Days
$363.06
Détails
Humain Lapin Inconjugué ICC, IHC, WB 100 μL 13 to 16 Days
$232.00
Détails
Souris Lapin Inconjugué ICC, IHC, WB 100 μL 13 to 16 Days
$239.00
Détails
Rat Lapin Inconjugué ICC, IHC, WB 100 μL 13 to 16 Days
$252.00
Détails
Humain Lapin Inconjugué IF (p), IHC (p) Formalin-fixed and paraffin embedded human endometrial cancer labeled with Anti-CCL28/MEC Polyclonal Antibody, Unconjugated (ABIN687067) followed by conjugation to the secondary antibody and DAB staining Formalin-fixed and paraffin embedded human breast carcinoma labeled with Anti CCL28/MEC Polyclonal Antibody, Unconjugated (ABIN687067) at 1:200 followed by conjugation to the secondary antibody and DAB staining 100 μL 3 to 7 Days
$327.80
Détails
Humain Lapin Inconjugué ELISA, WB   100 μL 11 to 13 Days
$331.65
Détails
Humain Souris Inconjugué WB Western Blot analysis of CCL28 expression in transfected 293T cell line by CCL28 MaxPab polyclonal antibody.Lane1:CCL28 transfected lysate(13.97 KDa).Lane2:Non-transfected lysate. 50 μL 11 to 12 Days
$440.00
Détails

Plus d’anticorps contre CCL28 partenaires d’interaction

Cow (Bovine) Chemokine (C-C Motif) Ligand 28 (CCL28) interaction partners

  1. Results identified chemotactic and antimicrobial properties of bCCL28 indicating that this chemokine may contribute to immune protection of the mammary gland, and the resolution or prevention of bovine mastitis.

  2. Quantitative mRNA analysis shows that these molecules exhibit unique expression patterns and suggest that these chemokines play a major role in the accumulation of receptor bearing cells to specific mucosal tissues.

Human Chemokine (C-C Motif) Ligand 28 (CCL28) interaction partners

  1. this review discusses the role of CCL28 in innate and adaptive immunity

  2. Results show that CCL28 expression was up-regulated under hypoxic condition in lung adenocarcinoma cells. Besides other effects on tumor biology such as immunosuppression, CCL28 could promote angiogenesis in lung adenocarcinoma by directly activating its receptor, CCR3, on microvascular endothelial cells.

  3. our results show for the first time that CCL28 contributes to breast cancer progression through the ERK/MAPKmediated anti-apoptotic and metastatic signaling pathway. Antagonists of CCL28 and the MAPK signaling pathway may be used synergistically to treat breast cancer patients.

  4. HCC recruits Tregs to promote angiogenesis under hypoxic condition by upregulating CCL28 expression. These findings establish a link between Tregs and hypoxia in HCC growth and may provide a new potential therapeutic target for treating HCC.

  5. CCL28 was absent in saliva of primary Sjogren's syndrome patients. This finding did not correlate with salivary IgA levels.

  6. disease severity of atopic dermatitis in children is not correlated to the level of CCL28, but rather related to that of total IgE

  7. CCL28-CCR3 interactions are involved in the homeostatic trafficking of CD4(+) T cells to the upper airways.

  8. High CCL28 gene methylation is associated with gastric tumor aggressiveness.

  9. CCL28 is a potent growth-promoting factor with the ability to support the in vitro and in vivo functional properties of cultured human hematopoietic cells.

  10. These results indicate a role for IL-17A in the human lung by enhancing the expression of CCL28 and hence driving the recruitment of IgE-secreting B cells.

  11. tumour hypoxia promotes the recruitment of regulatory T (T(reg)) cells through induction of expression of the chemokine CC-chemokine ligand 28 (CCL28), which, in turn, promotes tumour tolerance and angiogenesis

  12. CCL28 may play dual roles in mucosal immunity as a chemoattractant for cells expressing CCR10 and/or CCR3 such as plasma cells and also as a broad-spectrum antimicrobial protein secreted into low-salt body fluids.

  13. CCR10 and its mucosal epithelial ligand CCL28 have roles in the migration of circulating IgA plasmablasts

  14. CCL28 produced by keratinocytes is mediated by different signal pathways from CCL27, and both CCL27 and CCL28 are involved in the pathogenesis of inflammatory skin diseases.

  15. CCL28 is one link between microbial insult and the exacerbation of pathologies such as asthma, through an NFkappaB-dependent mechanism

  16. Expression of CCL28 by epithelial cells from chronically inflamed liver in response to microbial products or interleukin-1 provides a signal to localize CCR10-expressing regulatory T cells at mucosal surfaces.

  17. CCL28 mediates mucosal immunity in HIV exposure and infection

  18. These studies are the first to show increased CCL28 production during gastrointestinal infection in humans and provide an explanation for the large influx of IgA-secreting cells to the gastric mucosa in H. pylori-infected individuals.

  19. There was a robust migration of specific IgA- and IgM-antibody-secreting cells induced by Salmonella vaccination toward the mucosal chemokines CCL25 and CCL28

  20. data reinforce concept that CCL28 may contribute to the pathogenesis of atopic dermatitis probably through selective migration & infiltration of effector/memory T-helper-2 cells in the skin; CCL28 may represent a prognostic marker for disease severity

Pig (Porcine) Chemokine (C-C Motif) Ligand 28 (CCL28) interaction partners

  1. Mucosae associated-epithelial chemokine (MEC/CCL28) cloned from porcine salivary gland and colon tissues consisted of an open reading frame (ORF) of 384-bp coding for 127 amino-acids protein with 22 residues signal sequence.

Mouse (Murine) Chemokine (C-C Motif) Ligand 28 (CCL28) interaction partners

  1. Blockade of CCL28 or CCR10 during an acute severe respiratory paramyxoviral infection is sufficient to prevent the development of post-viral airway disease. However, the mechanism of action is unclear and requires further exploration.

  2. Plasmid codelivery of murine CCL19 and CCL28 enhanced Ag-specific systemic and mucosal Ab responses to HIV-1 gp140, augmented balanced Th1/Th2 responses, and increased lymphocyte subsets in various lymphoid tissues.

  3. These data suggest that CCL28 could be useful in enhancing the IgA immune response that will likely play a pivotal role in prophylactic HIV vaccines.

  4. tumour hypoxia promotes the recruitment of regulatory T (T(reg)) cells through induction of expression of the chemokine CC-chemokine ligand 28 (CCL28), which, in turn, promotes tumour tolerance and angiogenesis

  5. demonstrate that interactions between the antimicrobial C-terminus of CCL28 with an appropriate CC chemokine N-terminal domain is important for the full antimicrobial activity of CCL28.

  6. CCL28 has dual functions in mucosal immunity as a chemokine attracting cells expressing CCR10 and/or CCR3 and also as an apically secreted molecule with a potent antimicrobial activity against a broad spectrum of microbes.

  7. MEC attracts IgA- but not IgG- or IgM-producing plasmablasts from both intestinal and nonintestinal lymphoid and effector tissues, including the intestines, lungs, and lymph nodes draining the bronchopulmonary tree and oral cavity.

  8. Epithelial cells and venular endothelium of both small intestine and colon are positive for CCL28; CCL28 plays a direct role in intestinal homing of IgA antibody-secreting cells by mediating their extravasation into intestinal lamina propria.

  9. CCL28 is a key regulator of IgA ASC accumulation in the mammary gland and thus controls the passive transfer of IgA antibodies from mother to infant.

  10. CCL28 appears to play a role in regulating eosinophil recruitment to peribronchial regions of the lung possibly by coordinated temporal production with eotaxin

  11. CCL28 mediates mucosal immunity in HIV exposure and infection

CCL28 profil antigène

Profil protéine

This gene belongs to the subfamily of small cytokine CC genes. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene displays chemotactic activity for resting CD4 or CD8 T cells and eosinophils. The product of this gene binds to chemokine receptors CCR3 and CCR10. This chemokine may play a role in the physiology of extracutaneous epithelial tissues, including diverse mucosal organs.

Gene names and symbols associated with CCL28

  • C-C motif chemokine ligand 28 (Ccl28) anticorps
  • C-C motif chemokine ligand 28 (CCL28) anticorps
  • C-C motif chemokine ligand 28 (ccl28) anticorps
  • ectodermal-neural cortex 1 (with BTB domain) (enc1) anticorps
  • C-C motif chemokine 28 (LOC100303767) anticorps
  • chemokine (C-C motif) ligand 28 (Ccl28) anticorps
  • CCK1 anticorps
  • ccl28 anticorps
  • enc-1 anticorps
  • Encr-3 anticorps
  • klhl35 anticorps
  • LOC100303767 anticorps
  • MEC anticorps
  • nrpb anticorps
  • pig10 anticorps
  • SCYA28 anticorps
  • tp53i10 anticorps
  • Xencr-3 anticorps

Protein level used designations for CCL28

C-C motif chemokine 28 , CC chemokine CCL28 , chemokine ligand 28 , chemokine CCL28/MEC , chemokine (C-C motif) ligand 28 , ectodermal-neural cortex (with BTB-like domain) , ectoderm neural cortex related-3 , CCL28 , chemokine (C-C motif) ligand 28 splice variant chi , mucosae-associated epithelial chemokine , small inducible cytokine A28 , small inducible cytokine subfamily A (Cys-Cys), member 28 , small-inducible cytokine A28 , chemokine CCL28 , mucosae-associated epithelial chemokine CCL28 , CC chemokine ligand 28

GENE ID SPECIES
114492 Rattus norvegicus
535328 Bos taurus
574221 Macaca mulatta
735978 Pan troglodytes
780500 Ovis aries
100196449 Salmo salar
100271761 Xenopus (Silurana) tropicalis
100303767 Oryctolagus cuniculus
56477 Homo sapiens
554303 Sus scrofa
56838 Mus musculus
448795 Canis lupus familiaris
Fournisseurs de qualité sélectionnés pour anti-CCL28 (CCL28) Anticorps
Avez-vous cherché autre chose?